Artificial Intelligence

Artificial intelligence, or AI, is an umbrella term for machine learning and deep learning. It is where a machine takes in information from its surroundings and, from that, makes the most optimal decision appropriate to the situation.

What does ChatGPT mean for Healthcare?

In this article, we discuss how ChatGPT may change the face of healthcare and, if it can do so ethically.

The Pros and Cons of Healthcare Chatbots

The Medical Industries That Are Most Likely to Be Impacted by Ai

Uncovering the Mystery of the Human Brain with Computational Neuroscience

Is Data at the Center of Healthcare for the Future?

Managing the Explosion of Healthcare Data to Harness its Power

Applying Deep Learning to Localization Microscopy

Artificial Intelligence in Cardiology

Artificial Intelligence and Deep Learning in Medicine

Machine Learning in Drug Development

Deep-Learning in Radiology

Artificial Intelligence and Life Science

See more featured articles »

Artificial Intelligence in Histopathology

Can Artificial Intelligence be used to Diagnose Brain Aneurysms?

Recent Developments in Health Technology

Artificial Intelligence in CBT

Ethical Considerations in AI-Driven Healthcare

AI-Powered Genomic Analysis: Revolutionizing the Detection of Genetic Mutations

Beyond Virtual Consultations: The Rise of AI-Driven Virtual Healthcare Assistants

The Role of AI in Pathogen Detection and Epidemic Prediction

Latest Artificial Intelligence News and Research

Chatbots for mental health pose new challenges for US regulatory framework

The regulatory gaps and potential health risks of artificial intelligence (AI)-driven wellness apps.

1 May 2024

AI-enabled ECG system significantly reduces hospital mortality rates by identifying at-risk patients

A study in Nature Medicine evaluated an AI-enabled electrocardiogram (ECG) system's ability to identify hospitalized patients at risk of death, demonstrating its effectiveness in reducing mortality by enhancing the rapid response systems (RRS) through real-time alerts and risk stratification.

30 Apr 2024

Garvan Institute and Illumina collaborate to transform the treatment of complex diseases

Illumina, a global genomics and human health company, has partnered with the Garvan Institute of Medical Research's TenK10K project to help transform the treatment of complex diseases, starting with autoimmune diseases, with a joint investment of $27 million AUD.

30 Apr 2024

Progression of subtle CT abnormalities in smokers predicts acute respiratory disease

Smokers who have small abnormalities on their CT scans that grow over time have a greater likelihood of experiencing acute respiratory disease events, according to a new study published today in Radiology, a journal of the Radiological Society of North America.

30 Apr 2024

AI-MARRVEL: A leap forward in diagnosing genetic diseases with over 98% precision

The knowledge-driven MARRVEL AI-based model (AIM) to identify Mendelian illnesses.

30 Apr 2024

FDA-approved surgical robots trend toward autonomy, study finds

A systematic review in npj Digital Medicine categorizes FDA-approved surgical robots by their levels of autonomy, highlighting a need for standardized definitions and greater regulatory clarity as these systems evolve towards higher autonomy.

29 Apr 2024

Unlocking the mechanisms of pluripotent cell's fate determination

As embryos, all complex organisms are partially made up of pluripotent stem cells, a term for cells that have the capacity to differentiate into any kind of cell: nerve cells, muscle cells, blood cells, skin cells, and the like.

29 Apr 2024

Assessing newborn nursing mechanics with modified pacifier technology and AI algorithms

A modified pacifier and AI algorithms to analyze the data it produces could determine if newborns are learning the proper mechanics of nursing, a recent study shows.

29 Apr 2024

American Heart Association funds four new projects to evaluate the role of race in predicting heart disease risk

People with heart disease may receive different care because of how race is interpreted in health risk calculators and other tools that help clinicians make treatment decisions.

29 Apr 2024

Heart Failure 2024: Cutting-edge science and stimulating discussions in heart failure management

Cutting edge science and stimulating discussions in heart failure management are in store at Heart Failure 2024, a scientific congress of the European Society of Cardiology (ESC).

29 Apr 2024

Majority of AI clinical trials report positive outcomes, yet concerns over generalizability persist

The state of randomized controlled trials (RCTs) for artificial intelligence (AI) algorithms in clinical practice.

29 Apr 2024

New blood test shows promise in early detection of ovarian cancer

A study reveals that glycoproteins in blood could be key biomarkers for early detection and staging of epithelial ovarian cancer, potentially allowing diagnosis through a simple blood test.

28 Apr 2024

Machine learning-powered robot streamlines genetic research process

University of Minnesota Twin Cities researchers have constructed a robot that uses machine learning to fully automate a complicated microinjection process used in genetic research.

26 Apr 2024

AI in healthcare shows promise in trials but needs real-world testing to ensure effectiveness

A comprehensive study published in The Lancet Digital Health analyzed the efficacy and challenges of AI in clinical settings, revealing a critical need for real-world testing and diverse research methodologies to ensure AI's reliable integration into healthcare.

25 Apr 2024

Revolutionary AI device utilizes few-molecule reservoir computing for blood glucose prediction

A collaborative research team from NIMS and Tokyo University of Science has successfully developed a cutting-edge artificial intelligence (AI) device that executes brain-like information processing through few-molecule reservoir computing.

25 Apr 2024

New national center at Penn State aims to advance understanding of complex biological systems

A $20 million grant from the U.S. National Science Foundation (NSF) will support the establishment and operation of the National Synthesis Center for Emergence in the Molecular and Cellular Sciences (NCEMS) at Penn State.

25 Apr 2024

Insilico Medicine's AI-designed drug ISM3412 receives FDA IND approval

Clinical stage artificial intelligence (AI)-driven drug discovery company Insilico Medicine announces that it has received approval from the U.S. Food and Drug Administration for its Investigational New Drug application for ISM3412, a small molecule inhibitor of MAT2A for the potential treatment of MTAP deleted cancers designed with Insilico's generative AI platform.

25 Apr 2024

Study illuminates the interplay between health care technologies and essence of compassionate care

Cross Country Healthcare, Inc., a pioneering force in tech-driven workforce solutions and advisory services, in collaboration with Florida Atlantic University's Christine E. Lynn College of Nursing, released its latest research findings in the fourth annual installment of the Future of Nursing Survey: "Embracing Technology While Preserving Humanity."

25 Apr 2024

Advancing medical treatment with causal machine learning

Machines can learn not only to make predictions, but also to handle causal relationships. An international research team shows how this could make therapies safer, more efficient, and more individualized.

25 Apr 2024

Putting genomic surveillance of pathogens at the forefront of future pandemic preparedness

The Covid-19 pandemic turned the world upside down. In fighting it, one of our most important weapons was genomic surveillance, based on whole genome sequencing, which collects all the genetic data of a given microorganism.

25 Apr 2024